EE+ POEM Archive
Adding dulaglutide only slightly decreases major adverse CV events in patients with T2DM and CVD risk factors (REWIND)
Adding dulaglutide only slightly decreases major adverse CV events in patients with T2DM and CVD risk factors (REWIND) is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Adding Dulaglutide Only Slightly Decreases Major Adverse CV Events in Patients With T2DM and CVD Risk Factors (REWIND)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314844/all/Adding_dulaglutide_only_slightly_decreases_major_adverse_CV_events_in_patients_with_T2DM_and_CVD_risk_factors__REWIND_.
Adding dulaglutide only slightly decreases major adverse CV events in patients with T2DM and CVD risk factors (REWIND). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314844/all/Adding_dulaglutide_only_slightly_decreases_major_adverse_CV_events_in_patients_with_T2DM_and_CVD_risk_factors__REWIND_. Accessed January 28, 2023.
Adding dulaglutide only slightly decreases major adverse CV events in patients with T2DM and CVD risk factors (REWIND). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314844/all/Adding_dulaglutide_only_slightly_decreases_major_adverse_CV_events_in_patients_with_T2DM_and_CVD_risk_factors__REWIND_
Adding Dulaglutide Only Slightly Decreases Major Adverse CV Events in Patients With T2DM and CVD Risk Factors (REWIND) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 January 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314844/all/Adding_dulaglutide_only_slightly_decreases_major_adverse_CV_events_in_patients_with_T2DM_and_CVD_risk_factors__REWIND_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adding dulaglutide only slightly decreases major adverse CV events in patients with T2DM and CVD risk factors (REWIND)
ID - 1314844
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314844/all/Adding_dulaglutide_only_slightly_decreases_major_adverse_CV_events_in_patients_with_T2DM_and_CVD_risk_factors__REWIND_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
